Director/PDMR Shareholding

RNS Number : 7775L
Advanced Medical Solutions Grp PLC
05 October 2016


5 October 2016

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)


            Director/PDMR and PCA Shareholding


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that it was notified on 30 September 2016 that Eddie Johnson, who is a Senior Manager and PDMR, had exercised 50,000 Ordinary Shares of 5p from the 2009 Executive Share Option Scheme and sold all 50,000 shares.


The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them



Details of the person discharging managerial responsibilities/person closely associated


Name: Eddie Johnson


Reason for the notification


Position/status: Senior Manager/PDMR


Initial notification/Amendment: Initial Notification


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor


Name:   Advanced Medical Solutions Group plc




Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594


Nature of the transaction:

·      Exercised 50,000 Ordinary Shares of 5p from the 2009 Executive Share Option Scheme;

·      Sale of 50,000 shares from the total shares exercised.


Price(s) and volume(s):

Sale of shares:






Aggregated information: (Relates to those shares sold only)

Aggregated volume: 50,000

Aggregated price: £2.289663


Date of the transaction: 30/09/2016


Place of the transaction: London Stock Exchange, AIM Market (XLON)



End –


For further information, please visit or contact:


Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Group Finance Director

Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys

Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Daniel Adams / Patrick Robb


About Advanced Medical Solutions Group plc see

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.

AMS’s products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 510 employees.  For more information please see

This information is provided by RNS
The company news service from the London Stock Exchange